co-infection

Documents about co-infection

• A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2#876940ClinicalTrials.gov
• Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of TVAX-028 in the Treatment of Chronic Hepatitis B#966226ClinicalTrials.gov
• Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above#1010719ClinicalTrials.gov
• SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients#876008ClinicalTrials.gov
• A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older#146286ClinicalTrials.gov
• Epidemiology of hepatitis B virus co-infection among people living with HIV in four countries in sub-Saharan Africa#232897PLOS
• Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections#914695ClinicalTrials.gov
• Co-receptor Tropism Determination of HIV-1 Subtype A Spread in the Russian Federation Using V3-based Genotyping Tools#844739ClinicalTrials.gov
• Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients#992756ClinicalTrials.gov
• Dataset for "The Aquareovirus VP7 Co-opts NF-κB Signaling to Facilitate Infection via IL-1β and HSP70/90"#191669Figshare
• To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years#283081ClinicalTrials.gov
• Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)#350022ClinicalTrials.gov
• Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis#1032748ClinicalTrials.gov
• The Shifting Landscape of HIV–Tuberculosis Co-Infection in the MENA Region with a Focus on Saudi Arabia: A Systematic Epidemiological Analysis over Three Decades#237347Springer Nature OA
• Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection#806560ClinicalTrials.gov
• Immiseal™ Dural Sealant Post-Market Registry Study#849802ClinicalTrials.gov
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection#969457ClinicalTrials.gov
• HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function#810082ClinicalTrials.gov
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients#841612ClinicalTrials.gov
• RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections#917015ClinicalTrials.gov
• A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years#28439ClinicalTrials.gov
• Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)#827390ClinicalTrials.gov
• Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users#842081ClinicalTrials.gov
• Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)#827831ClinicalTrials.gov
• Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients#917834ClinicalTrials.gov
• Sex-Specific Hemostatic Responses and Diagnostic Potential of Platelet Distribution Width (PDW) and D-Dimer in Mild COVID-19, Malaria, and Co-Infection in a Tropical Setting: A Case-Control Study in Port Harcourt, Nigeria#390899bioRxiv / medRxiv
• Long-term Immune Persistence of a Bivalent HPV Vaccine in Females From Study 311-HPV-1004#907072ClinicalTrials.gov
• Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection#860331ClinicalTrials.gov
• Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis#831794ClinicalTrials.gov
• This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity#869285ClinicalTrials.gov
• Protocol for a Pilot Quasi-Experimental Study on the Effect of Patient-Centered Education on HIV Virological Outcomes Among Adult People Live With HIV-HBV Co-Infection in North-West Ethiopia: Protocol for a Pilot Quasi-Experimental Study.#636531NCBI PubMed Central
• Seroprevalence and risk factors of HBV/HCV/HIV triple co-infection among HIV patients receiving HAART at a Tertiary Hospital in Makurdi, Nigeria#1055408ULRR
• A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China#826419ClinicalTrials.gov
• Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil#634634eScholarship
• A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes#879985ClinicalTrials.gov
• Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C#992246ClinicalTrials.gov
• Prevalence of pulmonary mycoses among patients with suspected pulmonary tuberculosis at the Infectious Disease Hospital, Kano, Nigeria: Prévalence des mycoses pulmonaires chez les patients présentant une suspicion de tuberculose pulmonaire à l'hôpital des maladies infectieuses de Kano, au Nigéria#329006African Journals Online